Cervical Cancer Drugs Market Research Reports

Global Cervical Cancer Partnering 2012 to 2018 - Product Thumbnail Image

Global Cervical Cancer Partnering 2012 to 2018

  • Report
  • 150 Pages
From
Cervical Cancer Forecast in 22 Major Markets 2016-2026 - Product Thumbnail Image

Cervical Cancer Forecast in 22 Major Markets 2016-2026

  • Report
  • 50 Pages
From
CAS 50-18-0 Cyclophosphamide Chemical World Report - Product Thumbnail Image

CAS 50-18-0 Cyclophosphamide Chemical World Report

  • Report
  • 2011 Pages
CAS 59-05-2 Methotrexate Chemical World Report - Product Thumbnail Image

CAS 59-05-2 Methotrexate Chemical World Report

  • Report
  • 2111 Pages
CAS 6055-19-2 Cyclophosphamide monohydrate Chemical World Report - Product Thumbnail Image

CAS 6055-19-2 Cyclophosphamide monohydrate Chemical World Report

  • Report
  • 2001 Pages
CAS 7413-34-5 Sodium methotrexate Chemical World Report - Product Thumbnail Image

CAS 7413-34-5 Sodium methotrexate Chemical World Report

  • Report
  • 2006 Pages
Vaginal Cancer R&D Pipeline Analysis Report, H2-2018 - Product Thumbnail Image

Vaginal Cancer R&D Pipeline Analysis Report, H2-2018

  • Report
  • 100 Pages
From
Cervical Intraepithelial Neoplasia R&D Pipeline Analysis Report, H2-2018 - Product Thumbnail Image

Cervical Intraepithelial Neoplasia R&D Pipeline Analysis Report, H2-2018

  • Report
  • 80 Pages
From
CAS 119413-54-6 Topotecan hydrochloride Chemical World Report - Product Thumbnail Image

CAS 119413-54-6 Topotecan hydrochloride Chemical World Report

  • Report
  • 2195 Pages
CAS 15663-27-1 Cisplatin Chemical World Report - Product Thumbnail Image

CAS 15663-27-1 Cisplatin Chemical World Report

  • Report
  • 2157 Pages
CAS 127-07-1 Hydroxyurea Chemical World Report - Product Thumbnail Image

CAS 127-07-1 Hydroxyurea Chemical World Report

  • Report
  • 2031 Pages
CAS Cyclophosphamide World Consumption Report - Product Thumbnail Image

CAS Cyclophosphamide World Consumption Report

  • Report
  • 2091 Pages
CAS Methotrexate World Consumption Report - Product Thumbnail Image

CAS Methotrexate World Consumption Report

  • Report
  • 2095 Pages
CAS Hydroxyurea World Consumption Report - Product Thumbnail Image

CAS Hydroxyurea World Consumption Report

  • Report
  • 2188 Pages
Vaccines 2018: World Market Analysis, Key Players, Trends, Pediatric and Adult Segments (Influenza, Cervical Cancer, Combinations, Hepatitis, Pneumococcal, MMR, Varicella, Poliovirus, HIB, Others) - Product Thumbnail Image

Vaccines 2018: World Market Analysis, Key Players, Trends, Pediatric and Adult Segments (Influenza, Cervical Cancer, Combinations, Hepatitis, Pneumococcal, MMR, Varicella, Poliovirus, HIB, Others)

  • Report
  • 264 Pages
From
Adult Vaccine Market, Global Analysis By Disease (Influenza, Cervical Cancer, Zoster, MMR , Pneumonia, Meningitis, Hepatitis, Tap , Varicella & Travel & Miscellaneous Vaccine) & Companies - Product Thumbnail Image

Adult Vaccine Market, Global Analysis By Disease (Influenza, Cervical Cancer, Zoster, MMR , Pneumonia, Meningitis, Hepatitis, Tap , Varicella & Travel & Miscellaneous Vaccine) & Companies

  • Report
  • 218 Pages
From
Avastin 2017 U.S. Promotional Audit Report - Product Thumbnail Image

Avastin 2017 U.S. Promotional Audit Report

  • Report
  • 25 Pages
From
Global Cervical Cancer Screening Market & Patients, by Test Type (Pap Smear, HPV DNA, VIA), 19 Countries Analysis & Forecast - Product Thumbnail Image

Global Cervical Cancer Screening Market & Patients, by Test Type (Pap Smear, HPV DNA, VIA), 19 Countries Analysis & Forecast

  • Report
  • 309 Pages
From
Cervical Intraepithelial Neoplasia (CIN) - Pipeline Review, H1 2018 - Product Thumbnail Image

Cervical Intraepithelial Neoplasia (CIN) - Pipeline Review, H1 2018

  • Drug Pipelines
  • 94 Pages
From
Cervical Cancer - Pipeline Review, H1 2018 - Product Thumbnail Image

Cervical Cancer - Pipeline Review, H1 2018

  • Drug Pipelines
  • 768 Pages
From
Loading Indicator

Cervical cancer is the second most common and the fifth most deadly cancer in women. Approximately 80% of cervical cancers occur in developing countries which makes emerging economies such as China a major target market for pharmaceutical companies in the cervical cancer sector. The following expert reports enable buyers to examine the essential issues: supply and demand, forecasts, drug development and discovery, licensing, SWOT analyses, key industry players and more. This is the place for the inside track on market entry opportunities, growth strategies, buyer solutions and potential industry alliances in the area of cervical cancer drug development. Show Less Read more

adroll